Dr Emily Chesshyre is a mid-career research fellow in clinical mycology at the NIHR Exeter Biomedical Research Centre, University of Exeter. Emily has worked as a clinical research fellow since February 2020 at the MRC Centre for Medical Mycology, University of Exeter, where she has undertaken her PhD in Aspergillus infection in children and young people with cystic fibrosis (CF) supervised by Professor Warris, Professor Shore, and Dr Warren. Emily’s research interests are in paediatric medical mycology, particularly Aspergillus in children with CF, and neonatal and paediatric invasive candidiasis. Emily is a paediatric consultant at the Royal Devon University Healthcare NHS Foundation Trust with expertise in paediatric infectious diseases and immunity. Emily trained in medicine at the University of Southampton and trained as a paediatrician in London, Malawi, and the South-West, completing higher specialist grid training at Bristol Children’s Hospital in paediatric infectious diseases, immunology, and allergy. Emily is a member of the Royal College of Paediatrics and Child Health, UK Paediatric Antimicrobial Stewardship network, British Paediatric Allergy, Infection and Immunity Group, British Society of Medical Mycology, and the European Society of Paediatric Infectious Diseases.
Prof. Dr. Adilia Warris is a Professor and Co-Director of the MRC Centre for Medical Mycology at the University of Exeter. She earned her M.D. from the University of Groningen in 1994 and her Ph.D. in Medical Science from Radboud University Nijmegen in 2004. She is a co-lead of the clinical mycology theme at the NIHR Exeter Biomedical Research Centre, Director of Training at the Exeter BRC, Chair of the Fungal Infection Working Group of PENTA Child Health, and President-Elect of the European Society of Paediatric Infectious Diseases. Her research focuses on host-fungus interactions, particularly in vulnerable patient groups, with an emphasis on Aspergillus species, including unique cases such as A. nidulans in CGD hosts and Aspergillus infections in cystic fibrosis patients.
